[Postcoital administration of diethylstilbestrol].
D000014:Abnormalities, Drug-Induced; D002273:Carcinogens; D002986:Clinical Trials as Topic; D003281:Contraceptives, Postcoital / Q000494:pharmacology*; D003282:Contraceptives, Postcoital, Hormonal / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D004054:Diethylstilbestrol / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D010064:Embryo Implantation / Q000187:drug effects*; D005260:Female; D006801:Humans; D011247:Pregnancy; D013723:Teratogens; D014599:Uterus / Q000187:drug effects
D002273:Carcinogens; D003281:Contraceptives, Postcoital; D003282:Contraceptives, Postcoital, Hormonal; D013723:Teratogens; D004054:Diethylstilbestrol
L'administration postcoïtale du diéthylstilbestrol